Pharmaceutical industry

19:24 EST 8 Nov 2017 | Topix

HIV, hepatitis B and C and tuberculosis can each be treated for less than $90 a year where generic drugs can be made available, Dzintars Gotham of Imperial College, London, reported at the 9th International AIDS Society Conference ... HIV-negative infants potentially exposed in utero to doses of the HIV protease inhibitor nelfinavir contaminated with the toxic compound ethyl methyl sulfone did not have an increased risk of birth abnormalities, nor is there any increased risk of ... The German health technology assessment agency IQWiG has announced that it finds no advantage in Descovy, a combination pill containing a new version of the HIV drug tenofovir, over its alternative, Truvada, which is the most widely-used HIV ... Merck has received a US license for its direct-acting antiviral combination of grazoprevir and elbasvir, to be marketed as Zepatier.

Original Article: Pharmaceutical industry


More From BioPortfolio on "Pharmaceutical industry"

Quick Search


Relevant Topics

Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...

Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...